Atherosclerosis and Osteoporosis. Common Targets for the Effects of Cardiovascular and Anti-osteoporotic Drugs (Part I). The Effect of Cardiovascular Drugs on Bone Strength
Daily use of antihypertensive and lipid-lowering drugs in clinical practice dictates the need for knowledge of their pleiotropic effects. The article presents the results of studies of the effect of cardiovascular drugs, such as statins, beta-blockers, ACE inhibitors, diuretics, calcium antagonists...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Столичная издательская компания
2019-03-01
|
| Series: | Рациональная фармакотерапия в кардиологии |
| Subjects: | |
| Online Access: | https://www.rpcardio.online/jour/article/view/1861 |
| _version_ | 1826949620429750272 |
|---|---|
| author | I. A. Skripnikova N. A. Alikhanova M. A. Kolchinа M. A. Myagkova O. V. Kosmatova |
| author_facet | I. A. Skripnikova N. A. Alikhanova M. A. Kolchinа M. A. Myagkova O. V. Kosmatova |
| author_sort | I. A. Skripnikova |
| collection | DOAJ |
| description | Daily use of antihypertensive and lipid-lowering drugs in clinical practice dictates the need for knowledge of their pleiotropic effects. The article presents the results of studies of the effect of cardiovascular drugs, such as statins, beta-blockers, ACE inhibitors, diuretics, calcium antagonists and nitrates on bone mineral density and fractures associated with osteoporosis. The mechanisms of action of drugs on bone mass, markers of bone metabolism, the frequency of fractures in osteoporosis are discussed. Most studies show that the use of cardiac drugs along with a positive effect on the vascular wall, slow bone resorption and increase bone mass. Knowledge of the additional effect on bone metabolism of drugs used in cardiovascular diseases allows to choose an adequate therapy and improve the prognosis of both diseases. |
| first_indexed | 2024-03-08T14:02:02Z |
| format | Article |
| id | doaj.art-6dde57d58060451b827056840bc6953a |
| institution | Directory Open Access Journal |
| issn | 1819-6446 2225-3653 |
| language | English |
| last_indexed | 2025-02-17T22:16:26Z |
| publishDate | 2019-03-01 |
| publisher | Столичная издательская компания |
| record_format | Article |
| series | Рациональная фармакотерапия в кардиологии |
| spelling | doaj.art-6dde57d58060451b827056840bc6953a2024-12-04T11:48:16ZengСтоличная издательская компанияРациональная фармакотерапия в кардиологии1819-64462225-36532019-03-01151697610.20996/1819-6446-2019-15-1-69-761576Atherosclerosis and Osteoporosis. Common Targets for the Effects of Cardiovascular and Anti-osteoporotic Drugs (Part I). The Effect of Cardiovascular Drugs on Bone StrengthI. A. Skripnikova0N. A. Alikhanova1M. A. Kolchinа2M. A. Myagkova3O. V. Kosmatova4National Medical Research Center for Preventive MedicineNational Medical Research Center for Preventive MedicineNational Medical Research Center for Preventive MedicineNational Medical Research Center for Preventive MedicineNational Medical Research Center for Preventive MedicineDaily use of antihypertensive and lipid-lowering drugs in clinical practice dictates the need for knowledge of their pleiotropic effects. The article presents the results of studies of the effect of cardiovascular drugs, such as statins, beta-blockers, ACE inhibitors, diuretics, calcium antagonists and nitrates on bone mineral density and fractures associated with osteoporosis. The mechanisms of action of drugs on bone mass, markers of bone metabolism, the frequency of fractures in osteoporosis are discussed. Most studies show that the use of cardiac drugs along with a positive effect on the vascular wall, slow bone resorption and increase bone mass. Knowledge of the additional effect on bone metabolism of drugs used in cardiovascular diseases allows to choose an adequate therapy and improve the prognosis of both diseases.https://www.rpcardio.online/jour/article/view/1861beta-blockerscalcium antagonistsstatinsdiureticsnitratesatherosclerosisbone mineral densityosteoporosisosteoporotic fracture |
| spellingShingle | I. A. Skripnikova N. A. Alikhanova M. A. Kolchinа M. A. Myagkova O. V. Kosmatova Atherosclerosis and Osteoporosis. Common Targets for the Effects of Cardiovascular and Anti-osteoporotic Drugs (Part I). The Effect of Cardiovascular Drugs on Bone Strength Рациональная фармакотерапия в кардиологии beta-blockers calcium antagonists statins diuretics nitrates atherosclerosis bone mineral density osteoporosis osteoporotic fracture |
| title | Atherosclerosis and Osteoporosis. Common Targets for the Effects of Cardiovascular and Anti-osteoporotic Drugs (Part I). The Effect of Cardiovascular Drugs on Bone Strength |
| title_full | Atherosclerosis and Osteoporosis. Common Targets for the Effects of Cardiovascular and Anti-osteoporotic Drugs (Part I). The Effect of Cardiovascular Drugs on Bone Strength |
| title_fullStr | Atherosclerosis and Osteoporosis. Common Targets for the Effects of Cardiovascular and Anti-osteoporotic Drugs (Part I). The Effect of Cardiovascular Drugs on Bone Strength |
| title_full_unstemmed | Atherosclerosis and Osteoporosis. Common Targets for the Effects of Cardiovascular and Anti-osteoporotic Drugs (Part I). The Effect of Cardiovascular Drugs on Bone Strength |
| title_short | Atherosclerosis and Osteoporosis. Common Targets for the Effects of Cardiovascular and Anti-osteoporotic Drugs (Part I). The Effect of Cardiovascular Drugs on Bone Strength |
| title_sort | atherosclerosis and osteoporosis common targets for the effects of cardiovascular and anti osteoporotic drugs part i the effect of cardiovascular drugs on bone strength |
| topic | beta-blockers calcium antagonists statins diuretics nitrates atherosclerosis bone mineral density osteoporosis osteoporotic fracture |
| url | https://www.rpcardio.online/jour/article/view/1861 |
| work_keys_str_mv | AT iaskripnikova atherosclerosisandosteoporosiscommontargetsfortheeffectsofcardiovascularandantiosteoporoticdrugspartitheeffectofcardiovasculardrugsonbonestrength AT naalikhanova atherosclerosisandosteoporosiscommontargetsfortheeffectsofcardiovascularandantiosteoporoticdrugspartitheeffectofcardiovasculardrugsonbonestrength AT makolchina atherosclerosisandosteoporosiscommontargetsfortheeffectsofcardiovascularandantiosteoporoticdrugspartitheeffectofcardiovasculardrugsonbonestrength AT mamyagkova atherosclerosisandosteoporosiscommontargetsfortheeffectsofcardiovascularandantiosteoporoticdrugspartitheeffectofcardiovasculardrugsonbonestrength AT ovkosmatova atherosclerosisandosteoporosiscommontargetsfortheeffectsofcardiovascularandantiosteoporoticdrugspartitheeffectofcardiovasculardrugsonbonestrength |